低级别胶质瘤:代谢与结构影像同分级及分子因素之间的关系
本观察性研究纳入96例经病理证实的低级别胶质瘤患者(45例II级、51例III级),分析术前11C-METH PET半定量指标与MRI特征、组织学分级及分子标志物的关系。组织学分级与SUVmax(P=0.002)、SUV比值(P=0.011)和MTB(P=0.001)相关,III级病灶数值更高。作者认为半定量PET指标可改善低级别胶质瘤的术前评估并支持临床决策。
要点
- 组织学分级与SUVmax(P=0.002)、SUV比值(P=0.011)、MTB(P=0.001)相关,III级病灶数值更高。
- MRI非强化病灶中,II级与III级的SUVmax(P=0.001)、SUV比值(P=0.003)、MTB(P<0.001)差异有统计学意义。
- SUVmax和SUV比值在异柠檬酸脱氢酶-1/2野生型病灶中更高(P<0.05)。
核心结论
- 11C-METH PET指标与组织学分级和分子谱显著相关。
- 半定量PET指标可改善低级别胶质瘤的术前评估,从而支持临床决策。
研究设计与样本
- 观察性研究,纳入96例经病理证实的低级别胶质瘤患者(51例男性、45例女性;年龄44.1±13.7岁;45例II级、51例III级)。
- 患者于2012年3月至2015年1月因肿瘤切除转诊,术前接受11C-METH PET检查。
- 11C-METH PET半定量指标包括最大标准化摄取值(SUVmax)、与正常脑组织的SUV比值和代谢性肿瘤负荷(MTB)。
- 将PET半定量指标与MRI特征、组织学诊断、异柠檬酸脱氢酶-1/2状态和1p/19q共缺失进行分析比较。
主要发现
- 组织学分级与SUVmax(P=0.002)、SUV比值(P=0.011)和MTB(P=0.001)相关,III级病灶数值更高。
- MRI非强化病灶中,SUVmax(P=0.001)、SUV比值(P=0.003)和MTB(P<0.001)在II级与III级之间差异有统计学意义。
- MRI病灶体积与MTB相关性差(r2=0.13)。
- SUVmax和SUV比值在异柠檬酸脱氢酶-1/2野生型病灶中更高(P<0.05)。
- SUV比值与1p19q共缺失的存在相关。
临床怎么用
- 作者认为半定量PET指标可改善低级别胶质瘤的术前评估,从而支持临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Positron emission tomography (PET) is a valuable tool for the characterization of brain tumors in vivo. However, few studies have investigated the correlation between carbon-11-methionine (11C-METH) PET metrics and the clinical, radiological, histological, and molecular features of patients affected by lower grade gliomas (LGGs). The present observational study evaluated the relationships between 11C-METH PET metrics and structural magnetic resonance imaging (MRI) findings with the histomolecular biomarkers in patients with LGGs who were candidates for surgery. METHODS: We enrolled 96 patients with pathologically proven LGG (51 men, 45 women; age 44.1 ± 13.7 years; 45 with grade II, 51 with grade III), who had been referred from March 2012 to January 2015 for tumor resection and had undergone preoperative 11C-METH PET. The semiquantitative metrics for 11C-METH PET included maximum standardized uptake value (SUVmax), SUV ratio to normal brain, and metabolic tumor burden (MTB). The PET semiquantitative metrics were analyzed and compared with the MRI features, histological diagnosis, isocitrate dehydrogenase-1/2 status, and 1p/19q codeletion. RESULTS: Histological grade was associated with SUVmax (P = 0.002), SUV ratio (P = 0.011), and MTB (P = 0.001), with grade III lesions showing higher values. Among the nonenhancing lesions on MRI, SUVmax (P = 0.001), SUV ratio (P = 0.003) and MTB (P < 0.001) were significantly different statistically for grade II versus grade III. The MRI lesion volume correlated poorly with MTB (r2 = 0.13). The SUVmax and SUV ratio were greater (P < 0.05) in isocitrate dehydrogenase-1/2 wild-type lesions, and the SUV ratio was associated with the presence of the 1p19q codeletion. CONCLUSIONS: The 11C-METH PET metrics correlated significantly with histological grade and the molecular profile. Semiquantitative PET metrics can improve the preoperative evaluation of LGGs and thus support clinical decision-making.
引用
- Riva M, Lopci E, Castellano A, et al. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors. World Neurosurg. 2019. PMID: 30797926. doi:10.1016/j.wneu.2019.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。